Apple and other major U.S. tech stocks tumble after President Donald Trump announces sweeping global tariffs, Nvidia falls ...

If there’s one thing that financial markets don’t like, it’s uncertainty – and President Trump’s tariffs have thrown a huge ...

Fund managers aren't acting like danger is imminent. Here's where they're putting money to work now, including 12 stocks they ...

As of Monday, the Nasdaq Composite index had tumbled more than 11% since the start of the year. On the contrary -- this can ...

This history is plotted in the chart below, courtesy of data from InsiderSentiment.com. This is the website maintained by ...

Jim Cramer in a latest program on CNBC talked about the winning sectors so far this year and said the trends show a "strange" ...

After a large settlement, much of 3M's business has stabilized, including many gauges of profitability. But the company isn't completely in the clear yet. In fact, there could be even more PFAS ...

Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge share purchases.

Axis Securities believes that the direct impact on India remains limited after US President Donald Trump imposed reciprocal ...

Just before Christmas, these Magnificent Seven stocks were riding high. But after the worst quarter for US stocks since autumn 2022, they've been battered.

Other names on the Nifty Pharma index that has a significant upside potential include Aurobindo Pharma and Ajanta Pharma, both of which have an upside potential of 23%.